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To investigate the possible mechanisms of sudden death and the 
potential role of electrophysiologic testing in congestive heart 
failure, this study evaluated the electrophysiologic substrate in a 
model of heart failure induced by rapid pacing. Seventeen mon· 
grel dogs underwent cardiac pacing at 220 to 240 beats/min for 5 
weeks (paced group) and 11 other dogs served as a sham-operated 
control group. Rapid pacing of the right ventricle produced 
clinical and hemodynamic features of congestive heart failure. 
Dogs in the paced group had prolonged cardiac conduction 
time as reflected by longer epicardial activation time (36.1 ± 2.4 
vs. 30.8 ± 0.8 ms, p < 0.05). The ventricular effective refractory 
period was significantly prolonged after the development of heart 
failure (141 ± 4 vs. 177 ± 5 ms, p < 0.01, at a basic pacing cycle 
length of 300 ms), whereas no significant change was found in the 
control group (140 ± 4 vs. 145 ± 4 ms, p = NS). The prolongation 
of the ventricular effective refractory period correlated with an 
increase in left ventricular end-diastolic pressure (r = 0.55, p < 
Complex ventricular arrhythmias are noted in approximately 
90% of patients with congestive heart failure (1) and are 
closely related to the severity of ventricular dysfunction 
(2,3). Patients with severe congestive heart failure have an 
increased risk of developing malignant ventricular arrhyth-
mias and sudden death (4). However, the efficacy of antiar-
rhythmic drug therapy in preventing sudden death is uncer-
tain (5), whereas angiotensin-converting enzyme inhibitors 
have been shown to reduce ventricular ectopic activity in 
patients with severe heart failure (6,7). The mechanisms 
underlying the genesis of ventricular arrhythmias in conges-
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0.001) and the ventricular effective refractory period correlated 
inversely with cardiac index (r = -0.49, p < 0.025). 
The rest membrane potential of ventricular muscle was less 
negative in the paced group compared with the control group 
(-80.7 ± 2.2 vs. -85.6 ± 2.2 mV, p < 0.05). Intracellularly 
recorded action potential duration of ventricular muscle was 
longer in the paced than in the control group (236 ± 9.8 vs. 198.9 
± 2.6 ms, p < 0.01, action potential duration at 90% repolariza-
tion). Eight dogs (48%) in the paced group developed ventricular 
fibrillation after the occurrence of heart failure, whereas no 
control dog had sustained arrhythmia. There was no significant 
difference in the inducibility of ventricular tachycardia by pro-
grammed stimulation between the paced and control groups. 
In conclusion, rapid pacing-induced cardiac dysfunction is 
associated with electrophysiologic changes that could contribute to 
sudden cardiac death. These changes are not reflected by induc-
ibility of sustained ventricular tachycardia. 
(JAm Coli Cardiol1992;19:444-9) 
tive heart failure are poorly understood and the cardiac 
electrophysiologic abnormalities specifically related to heart 
failure are not clear. 
Tachycardia-induced cardiomyopathy and ventricular 
dysfunction have been demonstrated in some patients with 
chronic supraventricular tachycardia (8,9). Experimentally, 
prolonged rapid pacing in the dog has been shown to produce 
clinical features of congestive heart failure, simulating con-
gestive cardiomyopathy (10-12), and this provides a model 
for studying cardiac electrophysiologic changes and arrhyth-
mogenesis in congestive heart failure. The objectives of the 
present study were to determine the electrophysiologic 
changes associated with the development of heart failure in 
this model and to explore the value of programmed stimula-
tion in assessing susceptibility to sudden cardiac death. 
Methods 
Study animals. Twenty-eight mongrel dogs were used; 17 
in the paced group and 11 in the control group. Baseline 
physical examination, electrocardiogram (ECG), blood 
white cell count and determinations of hemoglobin, serum 
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electrolytes and creatinine levels were obtained to exclude 
any unhealthy animal. The protocol was approved by the 
University Council on Animal Care of the University of 
Western Ontario and was carried out in accordance with the 
"Guidelines to the Care and Use of Experimental Animals" 
of the Canadian Council on Animal Care. 
Baseline study. Dogs were tranquillized with an intramus-
cular injection of acepromazine (0.3 to 0.4 mg/kg body 
weight) for transportation to the laboratory. They were 
anesthetized with a mixture of 4% halothane, nitrous oxide 
(2 liters/min), oxygen (lliter/min) and medical air (2 liters/ 
min) with use of a mask and then were intubated and 
ventilated at a rate of 10 to 12 breaths/min and tidal volume 
of 12 to 13 mllkg with use of the Hospital 300 Anesthesia 
Ventilator (Hospital Medical Corporation). Halothane in the 
mixture was subsequently reduced to 0.5% to 1%. A circu-
lating water blanket and controller were used to maintain 
body temperature at 37 ± l°C. Infusion of lactated Ringer's 
solution was maintained during the operation. 
A 7F pigtail catheter was inserted through an incision in 
the right femoral artery and placed in the left ventricle under 
fiuoroscopic guidance. A 6F quadripolar catheter and a 
tripolar electrode catheter were inserted through an incision 
in the left jugular vein and placed in the right atrium and right 
ventricle, respectively. Intracardiac electrograms were fil-
tered at 30 to 500 Hz. Intracardiac electrograms, ECG limb 
leads I and 11 and left ventricular pressure were processed, 
displayed continuously and recorded periodically on photo-
graphic paper at 50 to 100 mm/s with use of an Electronics 
For Medicine VR-16 recorder. The endocardium of the right 
ventricular apex was stimulated at a pulse duration of 2 ms 
and twice diastolic threshold with use of a Grass S88 
stimulator (Grass Medical Instruments). A custom-designed 
timer was used to trigger the stimulator. 
Ventricular effective refractory period was determined 
with use of a driving train (S1) of eight beats at a cycle length 
of 300 and 250 ms, followed by an extrastimulus (S2) that was 
decremented in 10-ms intervals. Responses were monitored 
on a Tektronix 5513 storage oscilloscope. Ventricular effec-
tive refractory period was defined as the longest S1S2 inter-
val at which S2 failed to elicit ventricular activation. 
Inducibility of ventricular arrhythmia was determined 
using programmed stimulation at basic pacing cycle lengths 
of 400, 300 and 250 ms and up to three extrastimuli. The 
second extrastimulus (S3) was started with the S1S2 interval 
fixed at 30 ms longer than the ventricular effective refractory 
period. The S2S3 interval was set at 80% of basic pacing 
cycle length, again with use of 10-ms scanning decrements 
until S3 failed to elicit ventricular activation. If double 
extrastimulation failed to induce arrhythmia, a third extra-
stimulus (S4) was added with a similar scanning procedure 
(that is, the s2s3 interval fixed at 30 ms longer than the 
longest S2S3 interval at which S3 failed to capture). Nonsus-
tained ventricular tachycardia was defined as tachycardia 
lasting between three consecutive beats to 30 s and self-
terminating. 
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On completion of the programmed stimulation protocol, 
the catheters were withdrawn and the right femoral artery 
was ligated. A unipolar screw-in pacing lead was inserted 
through the left jugular vein incision and the tip of the lead 
was positioned in the right ventricle. The proximal end of the 
lead was connected to a custom-modified Medtronic 5941 
programmable pulse generator that was subsequently im-
planted in a subcutaneous pocket in the neck. The pace-
maker was set at 70 beats/min in demand mode. After the 
closure of all incisions, the animals were allowed to recover 
from anesthesia and returned to their quarters. 
Twentyjour hours postoperatively, the pacemaker in the 
paced group was programmed to 240 beats/min and main-
tained at that rate for 3 weeks. In accord with previous 
experience with this animal model, the pacing rate was 
reduced to 220 beats/min for the next 2 weeks before restudy 
to produce severe heart failure without increasing mortality. 
The surface ECG was checked weekly to assure constant 
pacing. The pacemaker in the control dogs remained in 
demand mode at 70 beats/min. Body weight, blood white cell 
count, hemoglobin, hematocrit and serum creatinine, urea 
and electrolytes were also monitored weekly. 
Restudy. Five weeks after the initial study, the pace-
maker was turned off and the dog was transported to the 
laboratory and anesthetized, with use of the identical proce-
dures used in the baseline study. The ventricular effective 
refractory period and inducibility of ventricular arrhythmia 
were determined with catheter insertion through the right 
jugular vein. Care was taken to position the stimulation 
catheter distant from the site of the pacing lead. On comple-
tion of the programmed stimulation protocol, the chest was 
opened through a median sternotomy. The heart was ex-
posed and the ventricles were wrapped with a nylon sock 
containing 56 bipolar electrode buttons. Epicardial electro-
grams were processed by a computerized cardiac mapping 
system (CMS 1000, Biomedical Instrumentation). Isochronal 
activation maps were generated and the total activation time 
was calculated. In nine dogs (six in the paced and three in the 
control group) programmed stimulation was also under-
taken, stimulating the epicardium of the right ventricular 
outflow tract, apex and left ventricular free wall to evaluate 
dispersion of refractoriness and inducibility of ventricular 
arrhythmia. 
On completion of the restudy, the heart was removed and 
examined for size, ventricular weight and gross abnormali-
ties. The pericardium, lungs and abdominal organs were also 
examined. Papillary muscles were removed for cellular 
electrophysiologic study. 
Cardiac output measurement. In 10 dogs (5 in the paced 
and 5 in the control group), in addition to the electrophysi-
ologic study, a Swan-Ganz catheter was inserted through the 
right femoral vein into a pulmonary artery. Triplicate mea-
surements of cardiac output were obtained with use of 5 ml 
of iced dextrose injections and a 9520A Thermodilution 
Cardiac Output Computer (American Edwards Laborato-
ries) during sinus rhythm and right atrial pacing at a cycle 
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Table 1. Selected Hemodynamic Observations at Baseline and Restudy in the Paced and Control Groups 
Cardiac Index 
Cardiac Output (liters/min) (liters/kg per min) LVSP(mmHg) LVDP(mm Hg) 
Baseline Restudy Baseline Restudy Baseline Re study Baseline Re study 
Control group 3.81 ± 0.34 3.76 ± 0.20 0.18 ± 0.02 0.18 ± 0.01 104.8 ± 3.4 101.1 ± 3.5 2.8 ± 0.8 4.7 ± 0.9 
No. 5 5 5 5 11 11 11 11 
Paced group 3.46 ± 0.34 2.11 ± 0.38 0.18 ± 0.01 0.11 ± 0.03* 102.1 ± 3.8 72.9 ± 3.4* 3.5 ± 0.8 12.5 ± 1.6* 
No. 5 5 5 5 16 16 16 16 
*p < 0.01 compared with baseline. LVDP and LVSP = left ventricular diastolic and systolic pressure, respectively. Cardiac output and cardiac index were 
measured during right atrial pacing at a cycle length of 300 ms. 
length of 300 ms. Cardiac output was measured during both 
the initial study and the restudy in all 10 dogs. 
Microelectrode study. In 19 dogs (10 in the paced and 9 in 
the control group) at the end of in vivo study, a papillary 
muscle was dissected from the beating heart and immersed 
in cold Tyrode's solution. The preparation was mounted in a 
tissue bath and perfused with a 95% oxygen, 5% carbon 
dioxide balanced Tyrode's solution at a flow rate of 
12 ml/min. The temperature of the perfusion solution was 
monitored by a thermistor probe in the bath and maintained 
at 37 ± 1 oc by a heating pump. The composition of the 
Tyrode's solution at pH 7.38 to 7.44 was as follows (mM): 
sodium chloride 129, sodium bicarbonate 20, sodium phos-
phate, monobasic 0.9, magnesium sulfate 0.5, potassium 
chloride 4, calcium chloride 2.5 and glucose 5.5. 
Glass microelectrodes with tip resistance of 15 to 20 
megohms were used for transmembrane potential recording. 
A silver-silver chloride wire in a glass tube filled with an 
agar-3M potassium chloride mixture was positioned in the 
bath as a reference electrode. The tissue was stimulated at 
1 Hz through a bipolar silver wire electrode with use of a 
WPI 1381 pulse generator (World Precision Instruments, 
Inc.) connected to a WPI 1850A stimulus isolator. Trans-
membrane potentials were processed with use of a WPI FD 
223 electrometer and recorded on a Gould 2400s chart recorder 
at paper speeds of 50 to 100 mrnls. Transmembrane potential 
was also digitalized and analyzed with use of a custom-
designed computer system. Rest membrane potential, action 
potential amplitude and action potential duration at 50% and 
90% repolarization were derived from the computer. 
Statistical analysis. Values were expressed as mean val-
ues ± SEM. The unpaired t test was used to compare mean 
values between the control and paced groups. The difference 
between baseline study and restudy in each group was 
analyzed with the paired t test. The relation between hemo-
dynamic and electrophysiologic variables was evaluated by 
linear regression analysis. A p value $0.05 was considered 
significant. 
Results 
Indexes of heart failure (Table 1). One dog in the paced 
group died of spontaneous ventricular fibrillation. The others 
survived until restudy. There were multiple indexes of heart 
failure in the rapidly paced group but not in the control 
group. Twelve (71%) of the 17 dogs in the paced group were 
lethargic before re study, whereas no behavior change was 
noted in the control dogs. Cardiac output and cardiac index 
were significantly decreased at restudy in the paced group, 
but there was no significant change in the control group. Left 
ventricular systolic pressure was significantly decreased and 
the diastolic pressure was significantly increased after the 
occurrence of heart failure in the paced group, whereas no 
significant change was found in the control group. Although 
the heart was visibly dilated in the paced group, no signifi-
cant difference in ventricular weight was found between the 
paced and control groups (6.6 ± 0.2 vs. 6.4 ± 0.2 g/kg body 
weight, p = NS). Local fibrosis of the endocardium at the 
site of the permanent pacing lead was observed in both 
groups. In the paced group, 13 dogs (77%) had one or more 
of the following abnormal findings at postmortem examina-
tion: ascites in 8 (47%), pericardial effusion in 10 (59%) and 
multifocallung infarction in 3 (18%). No abnormalities were 
noted in the control group. No significant change in body 
weight was noted in either the paced group (20.1 ± 0.8 kg at 
baseline study vs. 20.2 ± 0.9 kg at re study, p > 0.05) or the 
control group (21.1 ± 1.2 kg at baseline study vs. 21.4 ± 
1.1 kg at re study, p > 0.05), but there was evident loss of 
muscle mass in the paced dogs. 
Serum electrolyte disturbances were not evident in either 
group. Hematocrit was significantly decreased in the paced 
group (40.3% vs. 46.3%, p < 0.05), whereas no significant 
change was found in the control group (44.5% vs. 44.3%, p > 
0.05). 
Ventricular fibrillation. This arrhythmia occurred in eight 
dogs (47%) in the paced group. In one dog it occurred 
spontaneously before restudy with ECG monitoring. In the 
other seven it occurred during restudy: initiated by sponta-
neous premature ventricular complexes without preceding 
evidence of ischemia or hypotension in four, preceded by 
bradycardia of sudden onset in two and induced by triple 
extrastimuli in one. High energy shocks were usually re-
quired to terminate ventricular fibrillation in these dogs. Five 
dogs developed electromechanical dissociation after defibril-
lation and could not be resuscitated and thus failed to 
complete the electrophysiologic re study. 
Ventricular effective refractory period. This was signifi-
cantly prolonged after development of heart failure in the 
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control paced 
Cycle Length = 300 ms 
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Cycle Length = 250 ms 
Figure 1. Bar graph of the ventricular effective refractory period at 
initial study and restudy in 11 dogs in each of the control and paced 
groups. The ventricular effective refractory period was shorter with 
a basic pacing cycle length of 250 ms (right four bars) than with a 
cycle length of 300 ms (left four bars) for both paced and control 
dogs. Dogs in the paced group whose ventricular effective refractory 
period was not obtained at restudy because of death from ventric-
ular fibrillation were not included. *p < 0.01 compared with data 
from the initial study. Hatched bars= baseline; cross-hatched bars= 
restudy. 
paced group, whereas there was no significant change in the 
control group (Fig. 1). Ventricular effective refractory period 
measured at different ventricular sites during restudy was 
consistently longer in the paced group than in the control 
group (Fig. 2). Dispersion of ventricular refractoriness was 
defined as the difference between the longest and the short-
est ventricular effective refractory period measured at dif-
ferent sites in the same heart and was similar in both groups 
(21 ± 5 .1 ms in the paced group vs. 28 ± 11.5 ms of the 
control group, p > 0.05). 
Ventricular tachycardia. Single and double extrastimuli 
did not induce ventricular tachycardia at initial study or 
restudy in either group. Triple extrastimuli of the right 
ventricular endocardium induced nonsustained ventricular 
tachycardia once each in Dogs 10 and 12 in the paced group 
(four to five beats) and in Dog 10 in the control group (three 
beats) at the initial study. On restudy, nonsustained ventric-
ular tachycardia was induced repeatedly in Dogs 6, 9 and 15 
in the paced group (four to nine beats) but only once each in 
the two dogs (Dogs 7 and 11; four beats) in the control group. 
Triple extrastimuli at multiple epicardial sites induced non-
sustained ventricular tachycardia repeatedly in two of six 
dogs in the paced group (Dogs 8 and 9; four to eight beats) 
but only once each in two of the three control dogs (Control 
Dogs 6 and 7; 3 and 12 beats). In the three dogs resuscitated 
from ventricular fibrillation, findings differed from those of 
the control group but there were no differences between 
values for ventricular effective refractory period, dispersion 
of ventricular refractoriness and inducibility of ventricular 
tachycardia and those of other dogs in the paced group. 
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Figure 2. Bar graph of the ventricular effective refractory period 
measured at restudy from different sites in six dogs in the paced 
group and in three dogs in the control group. *p < 0.01 and tp < 0.05 
compared with the control group. endo = endocardium; epi = 
epicardium; L VFW = left ventricular free wall; RV = right ventri-
cle; RVOT = right ventricular outflow tract. Cross-hatched bars = 
control group; hatched bars = paced group. 
Epicardial activation time. Epicardial activation patterns 
in sinus rhythm were similar in both groups, with the earliest 
epicardial breakthrough at the right ventricular anterior wall 
near the interventricular septum. However, the total epicar-
dial activation time was longer in the paced group than in the 
control group (36.4 ± 2.4 vs. 30.8 ± 0.8 ms, p < 0.05). 
Conduction slowing was evenly distributed as demonstrated 
by uniformity of interisochrone distance. 
Correlation with hemodynamics. Left ventricular dia-
stolic pressure was significantly correlated with ventricular 
effective refractory period (r = 0.52, p < 0.01). The increase 
in left ventricular diastolic pressure was positively corre-
lated with the prolongation of ventricular effective refractory 
period (r = 0.55, p < 0.001). There was also an inverse 
correlation between cardiac index and ventricular effective 
refractory period (r = -0.49, p < 0.025) but no correlation 
between cardiac output and ventricular effective refractory 
period (r = 0.13, p > 0.05). 
Microelectrode findings (Table 2). Rest membrane poten-
tial was decreased (less negative) and the action potential 
duration was significantly longer in the paced group than in 
the control group. Action potential duration at 90% repolar-
Table 2. Transmembrane Potentials During Microlectrode Studies 
Rest Pot Amplitude APD50 APD90 
(mY) (mY) (ms) (ms) 
Control group -85.6 ± 2.2 102.3 ± 2.0 157.9 ± 4.8 198.9 ± 2.6 
Paced group -80.7 ± 2.2 101.3 ± 2.2 182.9 ± 12.0 236.0 ± 9.8 
p value <0.05 >0.05 <0.05 <0.01 
APD50 and APD90 = action potential duration at 50% and 90% repolar-
ization, respectively; Pot = potential. 
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ization was significantly correlated with ventricular effective 
refractory period (r = 0.62, p < 0.01). 
Discussion 
Chronic supraventricular tachycardias have been re-
ported (8,9) to be able to induce ventricular dysfunction in 
patients. Similarly, in the present experimental study, the 
clinical features of congestive heart failure were produced in 
dogs after rapid pacing of the right ventricle for 5 weeks as 
manifested by lethargic behavior, decreased cardiac output, 
increased ventricular diastolic pressure and fluid retention. 
Despite visible dilation, total ventricular weight was not 
statistically different from that in the control group, indicat-
ing thinning of the ventricular wall in this model. 
Prolongation of ventricular effective refractory period. 
Significant prolongation of the ventricular effective refrac-
tory period and action potential duration was found after 
development of heart failure in the present study. Slowing of 
the inactivation of a calcium-activated inward current and a 
decrease in outward repolarizing current have been pro-
posed to explain the action potential prolongation produced 
by myocardial hypertrophy (13) and this might also have 
happened in the dogs with rapid pacing-induced heart fail-
ure. By placing the stimulation catheter distant from the site 
of the pacing lead, measurement of ventricular effective 
refractory period in the area of fibrosis caused by the pacing 
lead was avoided. Measurements at multiple epicardial sites 
also revealed a consistently longer ventricular effective 
refractory period in the paced group than in the control 
group. Furthermore, action potential duration of papillary 
muscle that was not affected by pacing lead-induced local 
fibrosis was also prolonged consistently. Therefore, the 
prolongation of the ventricular refractory period is a global 
abnormality associated with cardiac dysfunction. 
The inverse correlation of the ventricular effective refrac-
tory period with cardiac index suggests that the degree of 
electrophysiologic abnormality is related to the severity of 
cardiac dysfunction. Prolongation of the ventricular effective 
refractory period also correlated with an increase in left 
ventricular end-diastolic pressure, indicating that the loading 
condition and the increased stretch of ventricular wall may 
be factors causing the electrophysiologic change. 
Inducibility of ventricular tachycardia. Despite severe 
dilation of the heart in all dogs in the paced group, sustained 
ventricular tachycardia was not induced in any surviving 
animal; it may have been inducible in the nonsurvivors, but 
this could not be assessed. In contrast, ventricular fibrilla-
tion was common. There was no statistically significant 
difference in the inducibility of nonsustained ventricular 
tachycardia between the initial study and restudy or between 
the paced and control groups. This finding suggests that the 
susceptibility to ventricular fibrillation cannot be predicted 
by programmed stimulation in congestive heart failure, an 
observation consistent with the results of programmed stim-
ulation in dilated cardiomyopathy (14). The high incidence of 
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ventricular fibrillation with low inducibility of ventricular 
arrhythmia by programmed stimulation in the paced group 
suggests that the initiating mechanism of ventricular fibrilla-
tion may be other than a fixed reentry substrate. The 
possibility that ventricular fibrillation is initiated by mecha-
nisms other than reentry was suggested in an ischemia-
reperfusion model (15) and supported by the low inducibility 
of ventricular tachycardia by programmed stimulation in 
patients with cardiomyopathy who had a high prevalence of 
spontaneous ventricular arrhythmias (14). 
Transmembrane potential changes. Depletion of high en-
ergy phosphate has been demonstrated in heart failure 
induced by rapid pacing (10). Shortage of adenosine triphos-
phate (A TP) may cause dysfunction of the electrogenic 
sodium-potassium pump. Thus, the contribution of the elec-
trogenic sodium-potassium pump to rest membrane potential 
may be decreased, which in turn may produce partial depo-
larization of the rest membrane potential. The decreased rest 
membrane potential can lead to increased automaticity and 
thus constitute a substrate of arrhythmia. Impulse conduc-
tion velocity is also affected by rest membrane potential. 
Thus, the decreased rest membrane potential may contribute 
to conduction slowing as shown by increased total duration 
of epicardial activation. Disorganization of myocardial fiber 
orientation and collagen arrangement may also contribute to 
conduction slowing (16). Increased conduction distance 
caused by the dilation of the heart may prolong total activa-
tion time. 
Implications. The implications of the prolongation of the 
ventricular effective refractory period and action potential 
duration deserve further investigation. Agents that prolong 
the effective refractory period and action potential duration 
have been shown to induce early triggered activity experi-
mentally and torsade de pointes clinically (17-20). Recently, 
prolongation of action potential duration caused by myocar-
dial hypertrophy has been reported (21) to predispose the 
heart to early triggered activity and ventricular tachycardia. 
Whether prolongation of effective refractory period and 
action potential duration in the present study can produce 
early triggered activity and contribute to the high incidence 
of ventricular fibrillation deserves further study. 
We thank G. Kim Wood, AHT for excellent technical assistance. 
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